 Kelly Sullivan
Concepts (224)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Down Syndrome | 11 | 2023 | 361 | 2.430 |
Why?
| | Tumor Suppressor Protein p53 | 11 | 2023 | 494 | 2.420 |
Why?
| | Proteome | 2 | 2021 | 363 | 1.120 |
Why?
| | Apoptosis | 14 | 2023 | 2564 | 0.980 |
Why?
| | Liposarcoma | 1 | 2023 | 26 | 0.940 |
Why?
| | Proto-Oncogene Proteins c-mdm2 | 5 | 2023 | 80 | 0.880 |
Why?
| | Genes, p53 | 2 | 2012 | 70 | 0.860 |
Why?
| | Piperazines | 5 | 2022 | 327 | 0.860 |
Why?
| | Janus Kinase 1 | 1 | 2020 | 23 | 0.800 |
Why?
| | Janus Kinase 2 | 1 | 2020 | 32 | 0.790 |
Why?
| | Azetidines | 1 | 2020 | 30 | 0.790 |
Why?
| | Transcriptional Activation | 3 | 2022 | 367 | 0.780 |
Why?
| | Databases, Genetic | 1 | 2021 | 286 | 0.730 |
Why?
| | Transcriptome | 3 | 2021 | 782 | 0.700 |
Why?
| | Interferons | 4 | 2023 | 157 | 0.700 |
Why?
| | Neoplasms | 7 | 2023 | 2241 | 0.680 |
Why?
| | Tumor Suppressor Proteins | 4 | 2018 | 301 | 0.660 |
Why?
| | Metabolome | 1 | 2021 | 307 | 0.660 |
Why?
| | GTPase-Activating Proteins | 2 | 2015 | 75 | 0.650 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 2 | 2015 | 62 | 0.630 |
Why?
| | Hypersensitivity | 1 | 2020 | 254 | 0.610 |
Why?
| | Sulfonamides | 1 | 2020 | 458 | 0.610 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2018 | 1200 | 0.580 |
Why?
| | Caenorhabditis elegans Proteins | 2 | 2015 | 196 | 0.550 |
Why?
| | Antineoplastic Agents | 3 | 2023 | 2016 | 0.550 |
Why?
| | Protein Kinase Inhibitors | 3 | 2020 | 877 | 0.550 |
Why?
| | Isoquinolines | 1 | 2015 | 43 | 0.540 |
Why?
| | Mitochondrial Turnover | 1 | 2015 | 4 | 0.540 |
Why?
| | Immunity, Innate | 2 | 2020 | 757 | 0.510 |
Why?
| | DNA-Binding Proteins | 4 | 2017 | 1392 | 0.450 |
Why?
| | Cell Cycle Proteins | 4 | 2023 | 576 | 0.440 |
Why?
| | Reactive Oxygen Species | 1 | 2015 | 580 | 0.430 |
Why?
| | Proto-Oncogene Proteins c-met | 1 | 2012 | 72 | 0.420 |
Why?
| | Fibroblasts | 1 | 2016 | 853 | 0.420 |
Why?
| | Patient Selection | 1 | 2015 | 716 | 0.400 |
Why?
| | Imidazoles | 3 | 2020 | 241 | 0.390 |
Why?
| | Interferon-alpha | 3 | 2020 | 191 | 0.390 |
Why?
| | Cerebellar Neoplasms | 2 | 2022 | 127 | 0.370 |
Why?
| | Medulloblastoma | 2 | 2022 | 171 | 0.360 |
Why?
| | Membrane Proteins | 1 | 2015 | 1076 | 0.330 |
Why?
| | Trisomy | 2 | 2019 | 67 | 0.330 |
Why?
| | Gene Expression Profiling | 4 | 2021 | 1648 | 0.320 |
Why?
| | HCT116 Cells | 3 | 2017 | 76 | 0.300 |
Why?
| | Inflammation | 1 | 2017 | 2522 | 0.300 |
Why?
| | Biomarkers | 2 | 2021 | 3650 | 0.280 |
Why?
| | Humans | 30 | 2023 | 121723 | 0.250 |
Why?
| | Activating Transcription Factor 4 | 1 | 2023 | 19 | 0.240 |
Why?
| | Receptors, Interferon | 2 | 2023 | 52 | 0.240 |
Why?
| | Proteasome Inhibitors | 1 | 2023 | 47 | 0.240 |
Why?
| | Proto-Oncogene Proteins | 4 | 2023 | 678 | 0.230 |
Why?
| | Protein Phosphatase 2C | 1 | 2022 | 15 | 0.230 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2023 | 141 | 0.230 |
Why?
| | Animals | 14 | 2023 | 34126 | 0.230 |
Why?
| | Autophagy | 2 | 2018 | 321 | 0.220 |
Why?
| | Centrosome | 2 | 2023 | 61 | 0.220 |
Why?
| | Proto-Oncogene Proteins c-akt | 2 | 2015 | 424 | 0.220 |
Why?
| | Purines | 2 | 2020 | 170 | 0.220 |
Why?
| | Nuclear Proteins | 3 | 2017 | 611 | 0.220 |
Why?
| | Mice | 9 | 2023 | 15616 | 0.220 |
Why?
| | Cell Line, Tumor | 6 | 2023 | 2913 | 0.210 |
Why?
| | Hedgehog Proteins | 2 | 2023 | 176 | 0.210 |
Why?
| | Cilia | 2 | 2023 | 160 | 0.210 |
Why?
| | Cell Proliferation | 5 | 2022 | 2361 | 0.200 |
Why?
| | Cell Death | 1 | 2022 | 343 | 0.200 |
Why?
| | Datasets as Topic | 1 | 2021 | 109 | 0.200 |
Why?
| | Seroconversion | 1 | 2021 | 44 | 0.200 |
Why?
| | Access to Information | 1 | 2021 | 57 | 0.200 |
Why?
| | Pyrazoles | 2 | 2022 | 399 | 0.200 |
Why?
| | RNA Helicases | 1 | 2020 | 25 | 0.190 |
Why?
| | Toll-Like Receptors | 1 | 2020 | 169 | 0.190 |
Why?
| | Data Mining | 1 | 2021 | 139 | 0.190 |
Why?
| | Signal Transduction | 5 | 2023 | 4810 | 0.180 |
Why?
| | Cell Line | 5 | 2021 | 2814 | 0.180 |
Why?
| | Chromosomes, Human, Pair 21 | 1 | 2019 | 32 | 0.180 |
Why?
| | Protein Domains | 2 | 2017 | 216 | 0.180 |
Why?
| | Transcription, Genetic | 2 | 2017 | 1403 | 0.180 |
Why?
| | DNA Repair | 1 | 2021 | 204 | 0.180 |
Why?
| | Kynurenine | 1 | 2019 | 73 | 0.180 |
Why?
| | Metabolomics | 2 | 2021 | 545 | 0.180 |
Why?
| | Proteomics | 2 | 2023 | 885 | 0.170 |
Why?
| | Complement System Proteins | 2 | 2021 | 290 | 0.170 |
Why?
| | Forkhead Box Protein O3 | 1 | 2018 | 18 | 0.170 |
Why?
| | Receptors, Growth Factor | 1 | 2017 | 51 | 0.160 |
Why?
| | Protein Biosynthesis | 1 | 2020 | 415 | 0.160 |
Why?
| | Cyclin-Dependent Kinase 8 | 1 | 2017 | 42 | 0.160 |
Why?
| | Autoimmunity | 2 | 2023 | 834 | 0.160 |
Why?
| | T-Lymphocyte Subsets | 1 | 2019 | 376 | 0.150 |
Why?
| | Leukemia, Biphenotypic, Acute | 1 | 2017 | 3 | 0.150 |
Why?
| | Apoptosis Regulatory Proteins | 1 | 2018 | 203 | 0.150 |
Why?
| | Cell Cycle Checkpoints | 2 | 2020 | 91 | 0.150 |
Why?
| | Antigens | 1 | 2018 | 320 | 0.150 |
Why?
| | Caspases | 2 | 2015 | 278 | 0.150 |
Why?
| | Histidine Kinase | 1 | 2016 | 33 | 0.150 |
Why?
| | RNA-Binding Proteins | 1 | 2020 | 386 | 0.150 |
Why?
| | Case-Control Studies | 2 | 2021 | 3314 | 0.150 |
Why?
| | Enhancer Elements, Genetic | 1 | 2017 | 164 | 0.150 |
Why?
| | Proteolysis | 1 | 2017 | 142 | 0.140 |
Why?
| | Heart Defects, Congenital | 1 | 2023 | 714 | 0.140 |
Why?
| | Down-Regulation | 2 | 2017 | 639 | 0.140 |
Why?
| | Mice, Inbred C57BL | 3 | 2020 | 5052 | 0.140 |
Why?
| | Colonic Neoplasms | 1 | 2018 | 227 | 0.140 |
Why?
| | Adenosine Triphosphatases | 1 | 2016 | 166 | 0.140 |
Why?
| | Genomics | 1 | 2021 | 687 | 0.140 |
Why?
| | Young Adult | 3 | 2021 | 11215 | 0.140 |
Why?
| | BH3 Interacting Domain Death Agonist Protein | 1 | 2015 | 11 | 0.130 |
Why?
| | Pyrones | 1 | 2015 | 10 | 0.130 |
Why?
| | Caspase 8 | 1 | 2015 | 49 | 0.130 |
Why?
| | bcl-2-Associated X Protein | 1 | 2015 | 46 | 0.130 |
Why?
| | Azepines | 1 | 2015 | 75 | 0.130 |
Why?
| | Cells, Cultured | 3 | 2018 | 4145 | 0.130 |
Why?
| | Repressor Proteins | 1 | 2017 | 393 | 0.130 |
Why?
| | Heat-Shock Proteins | 1 | 2015 | 130 | 0.120 |
Why?
| | Transcription Factors | 2 | 2022 | 1628 | 0.120 |
Why?
| | Morpholines | 1 | 2015 | 109 | 0.120 |
Why?
| | Fluorouracil | 1 | 2015 | 158 | 0.120 |
Why?
| | Sequence Homology, Amino Acid | 1 | 2015 | 381 | 0.120 |
Why?
| | Aminobenzoates | 1 | 2013 | 7 | 0.120 |
Why?
| | Carrier Proteins | 1 | 2018 | 739 | 0.120 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2015 | 230 | 0.120 |
Why?
| | Naphthalenes | 1 | 2013 | 50 | 0.120 |
Why?
| | Monocytes | 1 | 2016 | 513 | 0.120 |
Why?
| | Female | 8 | 2021 | 63833 | 0.120 |
Why?
| | Cytokines | 2 | 2019 | 1904 | 0.120 |
Why?
| | Ligands | 1 | 2015 | 556 | 0.110 |
Why?
| | Carcinoma, Squamous Cell | 1 | 2018 | 624 | 0.110 |
Why?
| | RNA Interference | 1 | 2015 | 476 | 0.110 |
Why?
| | Enzyme Activation | 1 | 2015 | 856 | 0.110 |
Why?
| | Genes, Synthetic | 1 | 2012 | 16 | 0.110 |
Why?
| | Genes, Lethal | 1 | 2012 | 27 | 0.110 |
Why?
| | Triple Negative Breast Neoplasms | 1 | 2015 | 162 | 0.110 |
Why?
| | Male | 6 | 2021 | 60425 | 0.110 |
Why?
| | RNA, Small Interfering | 1 | 2015 | 576 | 0.110 |
Why?
| | Liver | 1 | 2020 | 1832 | 0.110 |
Why?
| | Protein Structure, Tertiary | 1 | 2015 | 833 | 0.110 |
Why?
| | Pyrimidines | 1 | 2015 | 393 | 0.110 |
Why?
| | Chronic Disease | 1 | 2017 | 1655 | 0.100 |
Why?
| | Telomerase | 1 | 2013 | 213 | 0.100 |
Why?
| | Caenorhabditis elegans | 1 | 2014 | 294 | 0.100 |
Why?
| | Lipids | 1 | 2015 | 607 | 0.100 |
Why?
| | Adult | 4 | 2021 | 32638 | 0.100 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 2113 | 0.100 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2948 | 0.090 |
Why?
| | Gene Expression Regulation | 2 | 2020 | 2499 | 0.090 |
Why?
| | Cell Cycle | 1 | 2012 | 577 | 0.090 |
Why?
| | Mitochondria | 1 | 2015 | 796 | 0.090 |
Why?
| | T-Lymphocytes | 1 | 2016 | 1795 | 0.080 |
Why?
| | Mutation | 2 | 2015 | 3516 | 0.080 |
Why?
| | Breast Neoplasms | 1 | 2018 | 1970 | 0.070 |
Why?
| | Lung Neoplasms | 1 | 2018 | 2237 | 0.070 |
Why?
| | Infant | 1 | 2017 | 8439 | 0.060 |
Why?
| | Middle Aged | 2 | 2021 | 28928 | 0.060 |
Why?
| | Child, Preschool | 1 | 2017 | 9771 | 0.060 |
Why?
| | Phenotype | 2 | 2023 | 3079 | 0.060 |
Why?
| | Eukaryotic Initiation Factor-2 | 1 | 2022 | 20 | 0.060 |
Why?
| | Centrioles | 1 | 2023 | 37 | 0.060 |
Why?
| | Child | 2 | 2022 | 19271 | 0.050 |
Why?
| | G2 Phase Cell Cycle Checkpoints | 1 | 2022 | 41 | 0.050 |
Why?
| | Protein Binding | 2 | 2020 | 2017 | 0.050 |
Why?
| | Hypoalbuminemia | 1 | 2021 | 28 | 0.050 |
Why?
| | Binding Sites | 2 | 2014 | 1248 | 0.050 |
Why?
| | Seroepidemiologic Studies | 1 | 2021 | 156 | 0.050 |
Why?
| | Polyribosomes | 1 | 2020 | 24 | 0.050 |
Why?
| | Disease Models, Animal | 2 | 2023 | 3798 | 0.050 |
Why?
| | Proto-Oncogene Proteins c-myc | 1 | 2021 | 124 | 0.050 |
Why?
| | Quinazolines | 1 | 2022 | 250 | 0.050 |
Why?
| | Nucleotide Motifs | 1 | 2020 | 33 | 0.050 |
Why?
| | Quinolinic Acid | 1 | 2019 | 6 | 0.050 |
Why?
| | Hematopoiesis | 1 | 2021 | 180 | 0.050 |
Why?
| | Biosynthetic Pathways | 1 | 2019 | 21 | 0.050 |
Why?
| | Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2019 | 43 | 0.050 |
Why?
| | 3' Untranslated Regions | 1 | 2020 | 147 | 0.050 |
Why?
| | Gene Silencing | 1 | 2020 | 178 | 0.040 |
Why?
| | Adolescent | 1 | 2017 | 19118 | 0.040 |
Why?
| | rhoA GTP-Binding Protein | 1 | 2018 | 79 | 0.040 |
Why?
| | Cellular Senescence | 1 | 2019 | 151 | 0.040 |
Why?
| | Transforming Growth Factor beta2 | 1 | 2018 | 36 | 0.040 |
Why?
| | Complement Activation | 1 | 2021 | 349 | 0.040 |
Why?
| | Hexokinase | 1 | 2017 | 13 | 0.040 |
Why?
| | Phosphorylation | 1 | 2022 | 1684 | 0.040 |
Why?
| | Glucose Transporter Type 3 | 1 | 2017 | 14 | 0.040 |
Why?
| | Phosphopyruvate Hydratase | 1 | 2017 | 36 | 0.040 |
Why?
| | Deoxyglucose | 1 | 2017 | 50 | 0.040 |
Why?
| | Cell Lineage | 1 | 2019 | 332 | 0.040 |
Why?
| | MCF-7 Cells | 1 | 2017 | 119 | 0.040 |
Why?
| | Ubiquitin-Conjugating Enzymes | 1 | 2017 | 12 | 0.040 |
Why?
| | Homeostasis | 1 | 2021 | 608 | 0.040 |
Why?
| | Gene Editing | 1 | 2017 | 66 | 0.040 |
Why?
| | Interleukin-1 Receptor-Associated Kinases | 1 | 2017 | 20 | 0.040 |
Why?
| | Cyclin-Dependent Kinases | 1 | 2017 | 116 | 0.040 |
Why?
| | Neoplasm Proteins | 1 | 2020 | 414 | 0.040 |
Why?
| | Cell Hypoxia | 1 | 2017 | 228 | 0.040 |
Why?
| | Mutagenesis, Site-Directed | 1 | 2017 | 379 | 0.040 |
Why?
| | T-Lymphocytes, Regulatory | 1 | 2019 | 357 | 0.040 |
Why?
| | Glycolysis | 1 | 2017 | 235 | 0.040 |
Why?
| | Myeloid-Lymphoid Leukemia Protein | 1 | 2017 | 66 | 0.040 |
Why?
| | Tumor Cells, Cultured | 1 | 2018 | 907 | 0.040 |
Why?
| | Interferon-gamma | 1 | 2019 | 747 | 0.040 |
Why?
| | Flow Cytometry | 1 | 2019 | 1107 | 0.040 |
Why?
| | Base Sequence | 1 | 2020 | 2217 | 0.040 |
Why?
| | Comorbidity | 1 | 2021 | 1630 | 0.030 |
Why?
| | Histone-Lysine N-Methyltransferase | 1 | 2017 | 99 | 0.030 |
Why?
| | Lymphocyte Activation | 1 | 2019 | 1069 | 0.030 |
Why?
| | Tumor Protein p73 | 1 | 2015 | 16 | 0.030 |
Why?
| | Aurora Kinase A | 1 | 2015 | 53 | 0.030 |
Why?
| | Phosphatidylinositol Phosphates | 1 | 2014 | 39 | 0.030 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2019 | 707 | 0.030 |
Why?
| | Gene Expression | 1 | 2019 | 1530 | 0.030 |
Why?
| | Serine Proteases | 1 | 2013 | 15 | 0.030 |
Why?
| | Cell Movement | 1 | 2018 | 909 | 0.030 |
Why?
| | Protein Conformation | 1 | 2016 | 864 | 0.030 |
Why?
| | Models, Biological | 1 | 2021 | 1771 | 0.030 |
Why?
| | Protein Transport | 1 | 2014 | 419 | 0.030 |
Why?
| | Chromatin | 1 | 2016 | 451 | 0.030 |
Why?
| | Phosphatidylinositol 3-Kinases | 1 | 2014 | 346 | 0.030 |
Why?
| | Telomere-Binding Proteins | 1 | 2013 | 89 | 0.030 |
Why?
| | Xenograft Model Antitumor Assays | 1 | 2015 | 769 | 0.030 |
Why?
| | Interleukin-1 | 1 | 2017 | 984 | 0.030 |
Why?
| | RNA, Messenger | 1 | 2020 | 2746 | 0.030 |
Why?
| | Cell Differentiation | 1 | 2019 | 1774 | 0.030 |
Why?
| | Hospitalization | 1 | 2021 | 1873 | 0.030 |
Why?
| | HeLa Cells | 1 | 2013 | 612 | 0.030 |
Why?
| | Biomarkers, Tumor | 1 | 2017 | 1066 | 0.030 |
Why?
| | Cell Survival | 1 | 2013 | 1091 | 0.020 |
Why?
| | RNA | 1 | 2014 | 859 | 0.020 |
Why?
|
|
Sullivan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|